Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Diabetes Right
  3. Rezvoglar (insulin glargine-aglr) injection Right
  4. What is the guidance for the administration of Rezvoglar™ (insulin glargine‑aglr)?
Search Rezvoglar (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Rezvoglar ™ (insulin glargine-aglr) injection

3 mL (100 units/mL)

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

What is the guidance for the administration of Rezvoglar™ (insulin glargine‑aglr)?

Proper administration and dosing of Rezvoglar require adherence to specific instructions.

US_cFAQ_REZ024_ADMINISTRATION
cFAQ
cFAQ
US_cFAQ_REZ024_ADMINISTRATION
en-US

Administration Instructions

Always check insulin labels before administration.1

Instruct patients on proper use and injection technique before initiating Rezvoglar™ (insulin glargine-aglr) 100 units/mL.1

Visually inspect the Rezvoglar KwikPen® for particulate matter and discoloration prior to administration. Only use if the solution is clear and colorless with no visible particles.1

Administer Rezvoglar subcutaneously into the abdominal area, thigh, or deltoid.1

Rotate injection sites within the same region from one injection to the next to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis.1

Do not dilute or mix Rezvoglar with any other insulin or solution.1

Do not administer Rezvoglar intravenously or via an insulin pump.1

Dosing Instructions

In patients with type 1 diabetes, use Rezvoglar concomitantly with short-acting insulin.1

Inject Rezvoglar subcutaneously once daily at any time of day but at the same time every day.1

Individualize and adjust the dosage of Rezvoglar based on the individual’s

  • metabolic needs
  • blood glucose monitoring results
  • glycemic control goal
  • type of diabetes, and
  • prior insulin use.1

Perform dosage adjustments of Rezvoglar under medical supervision and with appropriate glucose monitoring. Dosage adjustments may be needed with

  • changes in physical activity
  • changes in meal patterns, such as with macronutrient content or timing of food intake
  • episodes of acute illness, or
  • changes in renal or hepatic function.1

Enclosed Prescribing Information

REZVOGLAR™ (insulin glargine-aglr) injection, for subcutaneous use, Lilly

Reference

1Rezvoglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

Date of Last Review: April 04, 2022

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly